Clinical Trials Logo

Filter by:
NCT ID: NCT03832101 Recruiting - Multitasking Clinical Trials

Improvement of Facial Recognition Ability and Multitasking

Start date: February 13, 2018
Phase: N/A
Study type: Interventional

This study aims to determine the efficacy of training on facial recognition and multitasking. The researchers hypothesize that participants who have undergone facial recognition and multitasking training will demonstrate an improved facial recognition ability and performance in multi-tasking. The researchers also hypothesize that measures of sustained and selective attention will predict performance on multitasking tasks. This work sets the ground work for future research into if and how facial recognition and multitasking ability can be improved.

NCT ID: NCT03823300 Completed - Clinical trials for Wet Macular Degeneration

A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (LUCERNE)

Start date: March 11, 2019
Phase: Phase 3
Study type: Interventional

This study will evaluate the efficacy, safety, durability, and pharmacokinetics of faricimab administered at intervals as specified in the protocol, compared with aflibercept once every 8 weeks (Q8W), in participants with neovascular age-related macular degeneration (nAMD).

NCT ID: NCT03816241 Completed - Organ Donation Clinical Trials

Mechanisms of Nudges on Families' Decision-Making Process

Start date: September 2016
Phase: N/A
Study type: Interventional

As part of a larger study, participants are told to read 1 out of 4 anecdotes depicting an organ donation scenario where they are required to make a decision on behalf of their mother who has just suffered an accident. The participants are then surveyed on their attitudes towards organ donation.

NCT ID: NCT03815175 Completed - Clinical trials for Coronary Artery Disease

XIENCE 28 USA Study

Start date: February 25, 2019
Phase: N/A
Study type: Interventional

The XIENCE 28 USA Study is prospective, single arm, multi-center, open label, non-randomized trial to evaluate safety of 1-month (as short as 28 days) dual antiplatelet therapy (DAPT) in subjects at high risk of bleeding (HBR) undergoing percutaneous coronary intervention (PCI) with the approved XIENCE family (XIENCE Xpedition Everolimus Eluting Coronary Stent System [EECSS], XIENCE Alpine EECSS and XIENCE Sierra EECSS) of coronary drug-eluting stents.

NCT ID: NCT03814161 Active, not recruiting - Clinical trials for Geriatric, Frailty, Emergency Department

FRailty Among Elderly Emergency Department Patients With Outcome Measures

FREEDOM
Start date: January 20, 2019
Phase:
Study type: Observational

Our study aims to compare 4 clinical frailty scores, namely Clinical Frailty Scale (CFS), Edmonton Frail Scale (EFS), FRAIL 5-item scale (FRAIL) and SARC-F Sarcopenia Score (SARC-F), which can potentially be adopted for daily practice in the busy ED. It is timely as we projected that we will be seeing more elderly patients attending the ED for various medical and surgical conditions. Their attendance at the ED would be a good opportunity to screen for frailty among them, and to intervene to prevent adverse outcomes such as ED re-attendance or subsequent hospitalisation that might lead to poor functional outcomes and higher dependence on step-down care facilities.

NCT ID: NCT03813394 Not yet recruiting - Clinical trials for Metastatic Nasopharyngeal Cancer

Bevacizumab and Pembrolizumab Combination in EBER-ISH Positive NPC

2018/00947
Start date: May 1, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

This is a single center, randomized, phase Ib/II open-label study of pembrolizumab (pembro or MK-3475) with or without bevacizumab in patients with recurrent non-curable or metastatic nasopharyngeal carcinoma (NPC).

NCT ID: NCT03813290 Recruiting - Clinical trials for Generalised Anxiety Disorder

A Neuro-Technological Intervention for Adolescents With GAD

Start date: December 8, 2020
Phase: N/A
Study type: Interventional

This study aims to evaluate the safety and acceptability of a basic neuro-technological intervention in the treatment of adolescents with Generalised Anxiety Disorder (GAD). Our technology will deliver a mindfulness-based anxiety regulation intervention through a neuro- / bio-feedback-based virtual reality (VR) game interface that is driven by a novel algorithm.

NCT ID: NCT03811301 Active, not recruiting - Clinical trials for Spinal Cord Injuries

[BrainConnexion] - Neurodevice Phase I Trial

Start date: November 21, 2017
Phase: N/A
Study type: Interventional

This study aims to evaluate the safety of a wireless implantable neurodevice microsystem in tetraplegic patients, as well as the efficacy of the electrodes for long-term recording of neural activities and the successful control of an external device.

NCT ID: NCT03809975 Active, not recruiting - Osteoarthritis Clinical Trials

Collaborative Model of Care Between Orthopaedics and Allied Healthcare Professionals Trial (CONnACT)

Start date: September 18, 2018
Phase: N/A
Study type: Interventional

Osteoarthritis knee is the leading cause of chronic disability among older adults. Our current model of care is doctor-centric and inefficient leading to suboptimal use of allied health intervention for effective lifestyle and behaviour changes resulting in potentially, unnecessary surgery. The study is designed using an effectiveness-implementation hybrid study design utilizing a mixed methods approach. The hybrid study has dual aims. The primary aim is to evaluate the clinical effectiveness (pain, function and quality of life) of a 12-week multidisciplinary (Orthopaedics, Physiotherapy, Dietetics, Psychology) personalized, community-based program for patients with knee osteoarthritis through a randomized-controlled trial. The secondary aim is to obtain data that will inform the context for implementation and guide future wider scale application. The investigators hypothesize that this multidisciplinary program is clinically more effective in the treatment of knee osteoarthritis at 12 months compared to standard care.

NCT ID: NCT03803345 Completed - Metabolic Disease Clinical Trials

The Association of Maternal Night-Eating Pattern With Glucose Tolerance During Pregnancy

Start date: March 28, 2019
Phase:
Study type: Observational

This study aims to assess the associations of maternal food timing with glucose levels during pregnancy.